Augusto Villanueva, MD, PhD, is a distinguished translational researcher in cancers of the liver. His research interests are aimed at improving prognosis prediction in hepatocellular carcinoma (HCC) by incorporating information from high-throughput genomic data into clinical-based prognostic systems.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)